Micafungin (FK463), alone or in combination with other systemic antifungal agents, for the treatment of acute invasive aspergillosis
Top Cited Papers
- 1 November 2006
- journal article
- clinical trial
- Published by Elsevier in Journal of Infection
- Vol. 53 (5) , 337-349
- https://doi.org/10.1016/j.jinf.2006.03.003
Abstract
No abstract availableKeywords
Funding Information
- Astellas Pharma US
This publication has 47 references indexed in Scilit:
- Efficacy and Safety of Caspofungin for Treatment of Invasive Aspergillosis in Patients Refractory to or Intolerant of Conventional Antifungal TherapyClinical Infectious Diseases, 2004
- Invasive Aspergillosis in Critically Ill Patients without MalignancyAmerican Journal of Respiratory and Critical Care Medicine, 2004
- Invasive fungal infections in autologous stem cell transplant recipients: a nation‐wide study of 1188 transplanted patientsEuropean Journal of Haematology, 2004
- Pulmonary Infiltrates in Patients Receiving Long-term Glucocorticoid Treatment*Chest, 2003
- Disseminated Aspergillosis in Intensive Care Unit Patients: An Autopsy StudyJournal of Chemotherapy, 2003
- Efficacy and Safety of Voriconazole in the Treatment of Acute Invasive AspergillosisClinical Infectious Diseases, 2002
- Late onset of invasive aspergillus infection in bone marrow transplant patients at a university hospitalBone Marrow Transplantation, 2002
- Aspergillosis Case-Fatality Rate: Systematic Review of the LiteratureClinical Infectious Diseases, 2001
- Increasing Volume and Changing Characteristics of Invasive Pulmonary Aspergillosis on Sequential Thoracic Computed Tomography Scans in Patients With NeutropeniaJournal of Clinical Oncology, 2001
- NIAID mycoses study group multicenter trial of oral itraconazole therapy for invasive aspergillosisThe American Journal of Medicine, 1994